Adverse Drug Effects
Infliximab Can Increase Tuberculosis Risk
Published in Medical Letter on the CDC and FDA, November 11th, 2001
"Infliximab is a humanized antibody against tumor necrosis factor (alpha) (TNF-(alpha)) that is used in the treatment of Crohn's disease and rheumatoid arthritis," explained Dr. Joseph Keane and colleagues at the Boston University School of Medicine and the U.S. Food and Drug Administration (FDA) in Rockville, Maryland.
A disturbingly high incidence of tuberculosis was seen in patients treated with this drug, Keane and coauthors reported in the October 11, 2001 edition of the New...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Antibiotic Resistance
Drug-Resistant Pheumococcal Bacteria Increases With Overuse Of Drugs - AIDS And HIV Tuberculosis
Coinfection Increases HIV Replication - Dentistry
Little Evidence Fluoridation Reduces Tooth Decay - Funding
Congress Willing To Increase Money For U.S. Centers For Disease Control - Influenza
Healthy People Urged To Postpone Immunization Until November - Smallpox
Study Will Try Smaller Vaccine Dose - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
